All In MedTech

FDA Clearance Tracker · P950039-S036

ThinPrep Integrated Imager

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 18, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P950039-S036
Device name
ThinPrep Integrated Imager
Applicant
Hologic, Inc.
Applicant location
Malborough, MA
Received
Jul 31, 2017
Decided
Apr 18, 2018
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P950039

Device type

Device class
Class III

Every decision under product code MNM

FDA's approval statement

As written in FDA's record.

Approval of the Hologic ThinPrep® Integrated Imager. The device uses computer imaging technology to assist in primary cervical cancer screening of ThinPrep® Pap Test slides for the presence of atypical cells, cervical neoplasia, including its precursor lesions (Low Grade Squamous Intraepithelial Lesions, High Grade Squamous Intraepithelial Lesions), and carcinoma as well as all other cytologic criteria as defined by the Bethesda System: Terminology for Reporting Results of Cervical Cytology.

Source documents

Other decisions for Hologic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.